Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Juan J. Espinós, Cristina Vanrell, Ignasi Gich, Eulalia Urgell & Joaquim Calaf. (2017) Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. Gynecological Endocrinology 33:2, pages 148-151.
Read now
Read now
C. Theunissen, J. De Schepper, J. Schiettecatte, P. Verdood, E.L. Hooghe-Peeters & B. Velkeniers. (2005) MACROPROLACTINEMIA: CLINICAL SIGNIFICANCE AND CHARACTERIZATION OF THE CONDITION. Acta Clinica Belgica 60:4, pages 190-197.
Read now
Read now
Articles from other publishers (80)
Lokesh Kumar Sharma, Deep Dutta, Neera Sharma, Bindu Kulshreshtha, Sandhya Lal & Ritika Sethi. (2021) Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia. Journal of Laboratory Physicians 13:04, pages 353-357.
Crossref
Crossref
Khanh Quynh N. Nguyen, Rachel H. Langevin, Michael J. McPhaul & Ibrahim A. Hashim. (2021) Circulating macroprolactin exhibits molecular heterogeneity and is not exclusively an antibody complex. Clinica Chimica Acta 514, pages 90-95.
Crossref
Crossref
Robert Krysiak, Witold Szkróbka & Bogusław Okopień. (2019) Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study. Experimental and Clinical Endocrinology & Diabetes 129:01, pages 7-13.
Crossref
Crossref
Chao Yu, Fei Fan, Siqi Hu, Lingxin Meng, Dong Xu, Juan Wang, Lu Chen, Jingrui Liu, Ying Dong, Yifan Lu, Min Shen, Yanhong Zhai & Zheng Cao. (2020) Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia. Journal of Clinical Laboratory Analysis 34:11.
Crossref
Crossref
Juana Serret-Montaya, Jessie N. Zurita-Cruz, Miguel A. Villasís-Keever, Alejandra Aguilar-Kitsu, Claudia del Carmen Zepeda-Martinez, Irving Cruz-Anleu, Beatriz C. Hernández-Hernández, Sara R. Alonso-Flores, Leticia Manuel-Apolinar, Leticia Damasio-Santana, Abigail Hernandez-Cabezza & José C. Romo-Vázquez. (2020) Hyperprolactinemia as a prognostic factor for menstrual disorders in female adolescents with advanced chronic kidney disease. Pediatric Nephrology 35:6, pages 1041-1049.
Crossref
Crossref
Melahat Dirican, Hacer Ebru Açıkgöz & Emre Sarandöl. (2020) Evaluation of percentage recovery together with modified reference range in hyperprolactinemia. Turkish Journal of Biochemistry 45:1, pages 37-43.
Crossref
Crossref
Robert Krysiak, Karolina Kowalcze & Bogusław Okopień. (2019) Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 115-121.
Crossref
Crossref
Raad A. Haddad, Donald Giacherio & Ariel L. Barkan. (2019) Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clinical Diabetes and Endocrinology 5:1.
Crossref
Crossref
Nadine Binart, Jacques Young & Philippe Chanson. 2019. Prolactin Disorders. Prolactin Disorders
55
78
.
Lucio Vilar, Julio Abucham, José Luciano Albuquerque, Luiz Antônio Araujo, Monalisa F. Azevedo, Cesar Luiz Boguszewski, Luiz Augusto Casulari, Malebranche B. C. CunhaNetoNeto, Mauro A. Czepielewski, Felipe H. G. Duarte, Manuel dos S. Faria, Monica R. Gadelha, Heraldo M. Garmes, Andrea Glezer, Maria Helane Gurgel, Raquel S. Jallad, Manoel Martins, Paulo A. C. Miranda, Renan M. Montenegro, Nina R. C. Musolino, Luciana A. Naves, Antônio Ribeiro-OliveiraJúniorJúnior, Cíntia M. S. Silva, Camila Viecceli & Marcello D. Bronstein. (2018) Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Archives of Endocrinology and Metabolism 62:2, pages 236-263.
Crossref
Crossref
Sema Ciftci Dogansen, Gulsah Yenidunya Yalin & Sema Yarman. (2018) Assessment of macroprolactinemia inpatients with prolactinoma. Turkish Journal of Biochemistry 43:1, pages 71-75.
Crossref
Crossref
Kohzo Aisaka, Fujiko Tsuchiya, Masami Sueta, Kana Itabashi, Sayaka Nose, Akiko Hasegawa, Seiichiro Obata, Haruko Hiraike & Tetsuhiko Yokoyama. (2018) Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin. Endocrine Journal 65:2, pages 203-211.
Crossref
Crossref
Miro Kasum, Slavko Orešković, Ermin Čehić, Martina Šunj, Albert Lila & Emina Ejubović. (2017) Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia. Taiwanese Journal of Obstetrics and Gynecology 56:6, pages 719-724.
Crossref
Crossref
Anthony Emeka Madu. (2016) Management of Hyperprolactinaemia in Gynaecological Practice in Blackpool, United Kingdom, a Study of Earlier Experience, with a Review of Relevant Literature. Obstetrics & Gynecology International Journal 4:4.
Crossref
Crossref
Robert Krysiak, Beata Kowalska, Witold Szkróbka & Bogusław Okopień. (2016) A neutral effect of testosterone therapy on macroprolactin content in men with macroprolactinemia and late-onset hypogonadism. Pharmacological Reports 68:1, pages 139-143.
Crossref
Crossref
SusanbL. Samson, Amir H. Hamrahian & Shereen Ezzat. (2015) American Association of Clinical Endocrinologists, American College of Endocrinology Disease State Clinical Review: Clinical Relevance of Macroprolactin in the Absence or Presence of True Hyperprolactinemia. Endocrine Practice 21:12, pages 1427-1435.
Crossref
Crossref
Michael N. Fahie-Wilson & Thomas P. Smith. (2015) Identification of IgG-K type macroprolactin found in the serum of an 8-year-old girl. Clinica Chimica Acta 441, pages 10.
Crossref
Crossref
M. Kasum, D. Pavičić-Baldani, P. Stanić, S. Orešković, J-M. Šarić, J. Blajić & J. Juras. (2014) Importance of macroprolactinemia in hyperprolactinemia. European Journal of Obstetrics & Gynecology and Reproductive Biology 183, pages 28-32.
Crossref
Crossref
Sollip Kim & Young-Min Park. (2013) Serum Prolactin and Macroprolactin Levels among Outpatients with Major Depressive Disorder Following the Administration of Selective Serotonin-Reuptake Inhibitors: A Cross-Sectional Pilot Study. PLoS ONE 8:12, pages e82749.
Crossref
Crossref
Krithika Thirunavakkarasu, Pinaki Dutta, Subbiah Sridhar, Lakhbir Dhaliwal, G. R. V. Prashad, Shalini Gainder, Naresh Sachdeva & Anil Bhansali. (2013) Macroprolactinemia in hyperprolactinemic infertile women. Endocrine 44:3, pages 750-755.
Crossref
Crossref
Macarena Alpañés, Raúl Sanchón, Mª Ángeles Martínez-García, Elena Martínez-Bermejo & Héctor F. Escobar-Morreale. (2013) Prevalence of hyperprolactinaemia in female premenopausal blood donors. Clinical Endocrinology 79:4, pages 545-549.
Crossref
Crossref
Takashi Adachi, Naoki Hattori, Takashi Ishihara, Hirokazu Iida, Takanori Saito, Shigeo Miyashima & Akira Shimatsu. (2013) Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis. European Journal of Endocrinology 169:2, pages 203-209.
Crossref
Crossref
Krzysztof C Lewandowski, Danuta Gąsior-Perczak, Aldona Kowalska & Andrzej Lewiński. (2012) Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease. Thyroid Research 5:1.
Crossref
Crossref
Naoki Hattori, Takashi Adachi, Takashi Ishihara & Akira Shimatsu. (2012) The natural history of macroprolactinaemia. European Journal of Endocrinology 166:4, pages 625-629.
Crossref
Crossref
Serhat Isik, Dilek Berker, Yasemin Ates Tutuncu, Ufuk Ozuguz, Ferhat Gokay, Gonul Erden, Hatice Nursun Ozcan, Ferit Kerim Kucukler, Yusuf Aydin & Serdar Guler. (2011) Clinical and radiological findings in macroprolactinemia. Endocrine 41:2, pages 327-333.
Crossref
Crossref
Chih-Chin Lu & Ching-Jung Hsieh. (2012) The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients. The Kaohsiung Journal of Medical Sciences 28:2, pages 94-99.
Crossref
Crossref
Eva Landberg, Ulf Dahlström & Urban Alehagen. (2010) Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 48:1, pages 51-56.
Crossref
Crossref
Naoki Hattori, Takashi Ishihara, Yasuhiko Saiki & Akira Shimatsu. (2010) Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long‐term follow‐up. Clinical Endocrinology 73:6, pages 792-797.
Crossref
Crossref
I. R. Wallace, N. Satti, C. H. Courtney, H. Leslie, P. M. Bell, S. J. Hunter, D. R. McCance, B. Sheridan & A. B. Atkinson. (2010) Ten-Year Clinical Follow-Up of a Cohort of 51 Patients with Macroprolactinemia Establishes It as a Benign Variant. The Journal of Clinical Endocrinology & Metabolism 95:7, pages 3268-3271.
Crossref
Crossref
G A Mel'nichenko, N P Goncharov, L K Dzeranova, A D Dobracheva & I I Barmina. (2010) Clinical and laboratory aspects of investigations into prolactin isoforms by PEG precipitation and ultrafiltration techniques. Problems of Endocrinology 56:1, pages 19-25.
Crossref
Crossref
Naoki Hattori, Takashi Ishihara & Yasuhiko Saiki. (2009) Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clinical Endocrinology 71:5, pages 702-708.
Crossref
Crossref
T. Joseph McKenna. (2009) Should macroprolactin be measured in all hyperprolactinaemic sera?. Clinical Endocrinology 71:4, pages 466-469.
Crossref
Crossref
Patrícia Coelho de Soárez, Silvia Corral de Arêa Leão Souza, José Gilberto Henriques Vieira & Marcos Bosi Ferraz. (2009) The Effect of Identifying Macroprolactinemia on Health-Care Utilization and Costs in Patients with Elevated Serum Prolactin Levels. Value in Health 12:6, pages 930-934.
Crossref
Crossref
Lucille Kavanagh-Wright, Thomas P. Smith, James Gibney & T. Joseph McKenna. (2009) Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clinical Endocrinology 70:4, pages 599-605.
Crossref
Crossref
Andrew C. Don-Wauchope, Mariza Hoffmann, Mia le Riche & Brynne H. Ascott-Evans. (2009) Review of the prevalence of macroprolactinaemia in a South African hospital. Clinical Chemistry and Laboratory Medicine 47:7.
Crossref
Crossref
T Joseph McKenna & Thomas Smith. (2008) Hyperprolactinemia Due to Macroprolactin. The Endocrinologist 18:5, pages 249-254.
Crossref
Crossref
M. Jane Ellis, Maxine R. Reed & John H. Livesey. (2007) Cross-reactivities of macroprolactin and big-prolactin in three commercial immunoassays for prolactin: A chromatographic analysis. Clinical Biochemistry 40:16-17, pages 1285-1290.
Crossref
Crossref
Naoki Hattori, Yasuhisa Nakayama, Kaori Kitagawa, Tiesong Li & Chiyoko Inagaki. (2007) Development of Anti-PRL (Prolactin) Autoantibodies by Homologous PRL in Rats: A Model for Macroprolactinemia. Endocrinology 148:5, pages 2465-2470.
Crossref
Crossref
M. Jane Ellis, John H. Livesey & Steven G. Soule. (2006) Macroprolactin, big-prolactin and potential effects on the misdiagnosis of hyperprolactinemia using the Beckman Coulter Access Prolactin assay. Clinical Biochemistry 39:10, pages 1028-1034.
Crossref
Crossref
Paula Álvarez-Vázquez, Digna Rodríguez Pérez, Elías Álvarez García, Concha Páramo Fernández, Elena Hervás Abad & María Amalia Andrade Olivié. (2006) Significación clínica de la macroprolactina. Endocrinología y Nutrición 53:6, pages 374-378.
Crossref
Crossref
Abel Alfonso, Kimberly I. Rieniets & Robert A. Vigersky. (2006) Incidence and Clinical Significance of Elevated Macroprolactin Levels in Patients with Hyperprolactinemia. Endocrine Practice 12:3, pages 275-280.
Crossref
Crossref
H. Sadideen & R. Swaminathan. (2006) Macroprolactin: what is it and what is its importance?. International Journal of Clinical Practice 60:4, pages 457-461.
Crossref
Crossref
Christiane Coussieu. (2006) Prolactine. EMC - Biologie Médicale 1:3, pages 1-6.
Crossref
Crossref
R. Sapin & J.L. Schlienger. (2005) Macroprolactinémie. Immuno-analyse & Biologie Spécialisée 20:5, pages 280-285.
Crossref
Crossref
Johan SchiettecatteAnne Van OpdenboschEllen AnckaertJean De Schepper, Kris Poppe, Brigitte Velkeniers & Johan Smitz. (2005) Immunoprecipitation for Rapid Detection of Macroprolactin in the Form of Prolactin–Immunoglobulin Complexes. Clinical Chemistry 51:9, pages 1746-1748.
Crossref
Crossref
James Gibney, Thomas P. Smith & T. Joseph McKenna. (2005) Clinical relevance of macroprolactin. Clinical Endocrinology 62:6, pages 633-643.
Crossref
Crossref
Young Ju ChoiJun Goo KangSung Yeon KimEui Sil HongSang Wan KimChan Soo ShinSeong Yeon KimBo Youn ChoHong Kyu Lee. (2005) The Clinical Characteristics of Macroprolactinemia. Journal of Korean Society of Endocrinology 20:3, pages 216.
Crossref
Crossref
Frank Nawroth. (2005) Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?. Reproductive BioMedicine Online 11:5, pages 581-588.
Crossref
Crossref
M García, M E Colombani-Vidal, C C Zylbersztein, A Testi, J Marcos, A Arturi, J Babini & H E Scaglia. (2016) Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus. Lupus 13:8, pages 575-583.
Crossref
Crossref
José Gilberto Henriques Vieira, Sônia Kiiomi Nishida, Maria Teresa Faria de Camargo, Omar Magid Hauache, Rui Monteiro de Barros Maciel & Valéria Guimarães. (2003) “MacroLH”: Anomalous Molecular Form That Behaves as a Complex of Luteinizing Hormone (LH) and IgG in a Patient with Unexpectedly High LH Values. Clinical Chemistry 49:12, pages 2104-2105.
Crossref
Crossref
L. P. Pinto, F. W. F. Hanna, L. M. Evans, J. S. Davies, R. John & M. F. Scanlon. (2003) The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Clinical Endocrinology 59:5, pages 580-584.
Crossref
Crossref
Mark W. J. Strachan, Wei Leng Teoh, Andrew C. Don-Wauchope, John Seth, Mary Stoddart & Geoffrey J. Beckett. (2003) Clinical and radiological features of patients with macroprolactinaemia. Clinical Endocrinology 59:3, pages 339-346.
Crossref
Crossref
Lucio Vilar, Luciana A. Naves & Mônica Gadelha. (2003) Armadilhas no diagnóstico da hiperprolactinemia. Arquivos Brasileiros de Endocrinologia & Metabologia 47:4, pages 347-357.
Crossref
Crossref
Naoki Hattori. (2003) Macroprolactinemia: a New Cause of Hyperprolactinemia. Journal of Pharmacological Sciences 92:3, pages 171-177.
Crossref
Crossref
L. García Menéndez, A. Díez Hernández, C. Ciriza de los Ríos, M. Delgado Gómez, A. Orejas García, A.L. Fernández Erales, C. González Mateo & M. Fernández Fernández. (2003) Macroprolactina como causa de hiperprolactinemia. Método de detección y caracterización clínica de la entidad en 39 pacientes. Revista Clínica Española 203:10, pages 459-464.
Crossref
Crossref
Thomas P. Smith, Abdulwahab M. Suliman, Michael N. Fahie-Wilson & T. Joseph McKenna. (2002) Gross Variability in the Detection of Prolactin in Sera Containing Big Big Prolactin (Macroprolactin) by Commercial Immunoassays. The Journal of Clinical Endocrinology & Metabolism 87:12, pages 5410-5415.
Crossref
Crossref
Can Hekim, Henrik Alfthan, Jari T Leinonen & Ulf-Håkan Stenman. (2002) Effect of Incubation Time on Recognition of Various Forms of Prolactin in Serum by the DELFIA Assay. Clinical Chemistry 48:12, pages 2253-2256.
Crossref
Crossref
Omar M. Hauache, Antonio J. Rocha, Antonio C. M. MaiaJrJr, Rui M. B. Maciel & José Gilberto H. Vieira. (2002) Screening for macroprolactinaemia and pituitary imaging studies. Clinical Endocrinology 57:3, pages 327-331.
Crossref
Crossref
A. Glezer, C. B. D’Alva, L. R. Salgado, N. R. Musolino, P. Serafini, J. G. Vieira & M. D. Bronstein. (2002) Pitfalls in pituitary diagnosis: peculiarities of three cases. Clinical Endocrinology 57:1, pages 135-139.
Crossref
Crossref
José Gilberto H. Vieira. (2002) Macroprolactinemia. Arquivos Brasileiros de Endocrinologia & Metabologia 46:1, pages 45-50.
Crossref
Crossref
Rémy Sapin, Françoise Gasser & Daniel Grucker. (2002) Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia. Clinica Chimica Acta 316:1-2, pages 33-41.
Crossref
Crossref
Wolfgang Schneider, Sorana Marcovitz, Sameer Al-Shammari, Silene Yago & Simone Chevalier. (2001) Reactivity of macroprolactin in common automated immunoassays. Clinical Biochemistry 34:6, pages 469-473.
Crossref
Crossref
Fabio A. Cattaneo & Michael N. Fahie-Wilson. (2001) Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Journal of Neurosurgery 95:2, pages 334-337.
Crossref
Crossref
Georges Gilson, Patrick Schmit, Jean Thix, Jean-Paul Hoffman & René-Louis Humbel. (2001) Prolactin Results for Samples Containing Macroprolactin Are Method and Sample Dependent. Clinical Chemistry 47:2, pages 331-333.
Crossref
Crossref
Johan Schiettecatte, Jean De Schepper, Brigitte Velkeniers, Johan Smitz & André Van Steirteghem. (2001) Rapid Detection of Macroprolactin in tHe Form of Prolactin-Immunoglobulin G Complexes by Immunoprecipitation with Anti-human IgG-Agarose. Clinical Chemistry and Laboratory Medicine 39:12.
Crossref
Crossref
J. Rodríguez-Espinosa, O. Rajmil & J.L. Sánchez-Quesada. (2001) Hiperprolactinemia por macroprolactina y disfunción eréctil. Endocrinología y Nutrición 48:4, pages 117-119.
Crossref
Crossref
Michael Fahie-Wilson, Penelope Brunsden, John Surrey & Anthony Everitt. (2000) Macroprolactin and the Roche Elecsys Prolactin Assay: Characteristics of the Reaction and Detection by Precipitation with Polyethylene Glycol. Clinical Chemistry 46:12, pages 1993-1995.
Crossref
Crossref
AM Marteil, R Sapin & N Jeandidier. (2000) La macroprolactine : implications biologiques et cliniques. Immuno-analyse & Biologie Spécialisée 15:6, pages 396-401.
Crossref
Crossref
Rhys John, Ian F W McDowell, Maurice F Scanlon & Andy R Ellis. (2000) Macroprolactin Reactivities in Prolactin Assays: An Issue for Clinical Laboratories and Equipment Manufacturers. Clinical Chemistry 46:6, pages 884-885.
Crossref
Crossref
C Coussieu. (2000) Le dosage de la prolactine aujourd'hui. Immuno-analyse & Biologie Spécialisée 15:3, pages 186-190.
Crossref
Crossref
. (2000) High Proclatin Level. Journal of Neurosurgery 92:2.
Crossref
Crossref
J.M. Cabezas Agrícola & J. Cabezas-Cerrato. (2000) Manejo terapéutico de la hiperprolactinemia. Revista Clínica Española 200:10, pages 563-565.
Crossref
Crossref
A O Olukoga, T L Dornan & J W Kane. (2017) Three Cases of Macroprolactinaemia. Journal of the Royal Society of Medicine 92:7, pages 342-344.
Crossref
Crossref
Olukoga & Kane. (2001) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clinical Endocrinology 51:1, pages 119-126.
Crossref
Crossref
B. Cavaco, S. Prazeres, M. A. Santos, L. G. Sobrinho & V. Leite. (2014) Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. Journal of Endocrinological Investigation 22:3, pages 203-208.
Crossref
Crossref
AP Heaney, I Laing, L Walton, MW Seif, CG Beardwell & JRE Davis. (1999) Misleading hyperprolactinaemia in pregnancy. The Lancet 353:9154, pages 720.
Crossref
Crossref
José Gilberto H Vieira, Teresinha T Tachibana, Leda H Obara & Rui M B Maciel. (1998) Extensive Experience and Validation of Polyethylene Glycol Precipitation as a Screening Method for Macroprolactinemia. Clinical Chemistry 44:8, pages 1758-1759.
Crossref
Crossref
M N Fahie-Wilson & S G Soule. (2016) Macroprolactinaemia: Contribution to Hyperprolactinaemia in a District General Hospital and Evaluation of a Screening Test Based on Precipitation with Polyethylene Glycol. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:3, pages 252-258.
Crossref
Crossref
Jeanne S. E. Dericks-Tan, H.-G. Siedentopf & H.-D. Taubert. (1997) Discordant Prolactin Values obtained with Different Immunoassays in an Infertile Patient.. LaboratoriumsMedizin 21:9, pages 465-470.
Crossref
Crossref
. (1996) Reproductive Health LiteratureWatch. Journal of Women's Health 5:2, pages 153-168.
Crossref
Crossref